VAERS reports by lot

GSK DTaP/Tdap lot C472T: VAERS reports

37 VAERS reports list lot C472T as a GSK DTaP/Tdap vaccine, received between 2022-09-01 and 2024-10-10. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
37
Reports
0%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction556%
Dermatological (non-injection-site)333%
Musculoskeletal111%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Texas7
Michigan5
Illinois3
Ohio2
Arkansas2
New York2
Florida2
Alabama2
South Carolina1
Nebraska1
Vermont1
Utah1

Reports by month received

MonthReportsBar
2022-091
2022-102
2022-112
2022-123
2023-014
2023-025
2023-031
2023-041
2023-052
2023-071
2023-085
2023-094
2024-032
2024-041
2024-051
2024-102

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): B4C44 · B75MY · BR352 · CX4HL · D24G7 · DD7F7

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.